List of articles with "Eli Lilly"

Lilly at ASCO 2025

Lilly at ASCO 2025

USA Chicago Cancer Research Eli Lilly ASCO 2025
Kisunla Alzheimer's Approval

Kisunla Alzheimer's Approval

Indianapolis Australia Alzheimer's Disease Eli Lilly Kisunla
Rznomics & Eli Lilly Partnership

Rznomics & Eli Lilly Partnership

South Korea Rznomics Seongnam Eli Lilly RNA Therapy
Lilly's $250M Deal with Purdue

Lilly's $250M Deal with Purdue

United States Indianapolis Purdue University Eli Lilly Pharmaceutical Innovation
April Health Recap

April Health Recap

Crunch Fitness Eli Lilly Novartis AG
Eli Lilly Executive Changes

Eli Lilly Executive Changes

United States Indianapolis Leadership Eli Lilly growth
Alchemab and Eli Lilly

Alchemab and Eli Lilly

Cambridge United Kingdom Eli Lilly Alchemab ATLX-1282
Lilly Q2 2025 Dividend

Lilly Q2 2025 Dividend

United States Dividend Indianapolis Eli Lilly NYSE:LLY
Lilly at Healthcare Conference

Lilly at Healthcare Conference

United States Indianapolis Healthcare Conference Eli Lilly Lucas Montarce
Eli Lilly's Q1 2025 Results

Eli Lilly's Q1 2025 Results

United States Indianapolis Zepbound Eli Lilly Mounjaro
Cancer Risks and Antipsychotics

Cancer Risks and Antipsychotics

USA Johnson & Johnson Alameda Eli Lilly Risperdal
OrderlyMeds vs. Eli Lilly

OrderlyMeds vs. Eli Lilly

United States Atlanta tirzepatide Eli Lilly OrderlyMeds
Platinum Ticket Investments

Platinum Ticket Investments

United States Cambridge biotechnology Eli Lilly Mission BioCapital
Lepodisiran's Breakthrough

Lepodisiran's Breakthrough

United States Indianapolis Heart Disease Eli Lilly Lepodisiran
LillyDirect Alzheimer's Care

LillyDirect Alzheimer's Care

United States Indianapolis Alzheimer's Eli Lilly LillyDirect
VERZENIO Market Insights

VERZENIO Market Insights

USA Las Vegas Eli Lilly Verzenio CDK4/6 inhibitors
Baricitinib's Impact on Hair Loss

Baricitinib's Impact on Hair Loss

USA Indianapolis Eli Lilly Alopecia Areata Baricitinib
EBGLYSS® Breakthrough

EBGLYSS® Breakthrough

United States Indianapolis Atopic Dermatitis Eli Lilly EBGLYSS
Maria José Rueda Joins ASA

Maria José Rueda Joins ASA

United States New York Eli Lilly American Skin Association Maria José Rueda
Lilly at Global Healthcare

Lilly at Global Healthcare

United States Indianapolis Healthcare Conference Eli Lilly Lucas Montarce
Lilly Manufacturing Expansion

Lilly Manufacturing Expansion

USA Manufacturing pharmaceuticals Washington D.C. Eli Lilly
Lilly's New Zepbound Doses

Lilly's New Zepbound Doses

USA Indianapolis Zepbound tirzepatide Eli Lilly
2025 Goodes Prize

2025 Goodes Prize

United States New York Eli Lilly Daniel Skovronsky Goodes Prize
Lilly at Health Care Conference

Lilly at Health Care Conference

United States Indianapolis biotechnology Eli Lilly Health Care
Omvoh Sustains Remission

Omvoh Sustains Remission

United States Indianapolis Crohn's Disease Eli Lilly Omvoh
Lilly Q4 2024 Results

Lilly Q4 2024 Results

United States Indianapolis Zepbound Eli Lilly Mounjaro
Omvoh® Approved for Crohn's

Omvoh® Approved for Crohn's

United States Indianapolis Crohn's Disease Eli Lilly Omvoh
Lilly's Revenue Guidance

Lilly's Revenue Guidance

United States Indianapolis revenue growth Eli Lilly Phrmaceuticals
Lilly's New Acquisition

Lilly's New Acquisition

United States Indianapolis Eli Lilly Scorpion Therapeutics STX-478
Thrive Global and Eli Lilly Partnership

Thrive Global and Eli Lilly Partnership

United States New York Thrive Global Eli Lilly Health Outcomes
Lilly at J.P. Morgan

Lilly at J.P. Morgan

United States Indianapolis Healthcare Conference J.P. Morgan Eli Lilly
Kisunla™ Approved in China

Kisunla™ Approved in China

China Nanjing Alzheimer’s Eli Lilly Kisunla™
Innovent and Lilly Team Up

Innovent and Lilly Team Up

China Suzhou Innovent Biologics Eli Lilly Jaypirca
Ro and Lilly Team Up

Ro and Lilly Team Up

United States New York Zepbound Eli Lilly Ro
Lilly's Pirtobrutinib Results

Lilly's Pirtobrutinib Results

USA Indianapolis Eli Lilly CLL Pirtobrutinib
Lilly's $15 Billion Program

Lilly's $15 Billion Program

United States Indianapolis share repurchase dividend increase Eli Lilly
Kidney Health at Rose Parade

Kidney Health at Rose Parade

United States Los Angeles Boehringer Ingelheim Eli Lilly CORE Kidney
Cambrex & Eli Lilly Alliance

Cambrex & Eli Lilly Alliance

USA biotech Longmont, Colorado Cambrex Eli Lilly
Lilly's $3 Billion Expansion

Lilly's $3 Billion Expansion

United States pharmaceuticals Eli Lilly Wisconsin Expansion Kenosha County
Cambrex and Eli Lilly Agreement

Cambrex and Eli Lilly Agreement

USA biotechnology Cambrex Eli Lilly East Rutherford
Cambrex & Eli Lilly Unite

Cambrex & Eli Lilly Unite

USA biotech Longmont Cambrex Eli Lilly
Cambrex and Lilly Collaboration

Cambrex and Lilly Collaboration

USA biotech Longmont Cambrex Eli Lilly
Cambrex and Eli Lilly Partnership

Cambrex and Eli Lilly Partnership

USA Longmont, Colorado Cambrex Eli Lilly Biotech Partners

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.